LifeTech Scientific Corporation (HKG:1302)

Market Cap	9.26B +41.9%
Revenue (ttm)	1.52B +5.1%
Net Income	164.50M -33.5%
EPS	0.04 -35.0%
Shares Out	4.63B
PE Ratio	54.46
Forward PE	17.37
Dividend	n/a
Ex-Dividend Date	n/a

Volume	27,514,000
Average Volume	29,618,422
Open	2.020
Previous Close	2.000
Day's Range	1.930 - 2.020
52-Week Range	1.470 - 2.440
Beta	0.39
RSI	50.14
Earnings Date	Aug 28, 2026

About LifeTech Scientific

LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asia, India, South America, Africa, and internationally. It operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. The company’s products include LAmbre left atrial appendage closure systems, as well as CeraFlex, Cera, ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 1,245
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1302

Financial Performance

In 2025, LifeTech Scientific's revenue was 1.37 billion, an increase of 5.07% compared to the previous year's 1.30 billion. Earnings were 147.83 million, a decrease of -33.53%.

Financial numbers in CNY